Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haineng Xu

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cancer Treatment and Research|November 17, 2023
Combination DNA Damage Response (DDR) Inhibitors to Overcome Drug Resistance in Ovarian CancerDimitrios Nasioudis, Erin M George, Haineng Xu, et al.
Journal of Cancer|January 22, 2019
High Expression of Indoleamine 2, 3-Dioxygenase in Adenosquamous Lung Carcinoma Correlates with Favorable Patient OutcomeWenjuan Ma, Hao Duan, Rongxin Zhang, et al.
American Journal of Cancer Research|April 14, 2016
CD24 negative lung cancer cells, possessing partial cancer stem cell properties, cannot be considered as cancer stem cellsHaineng Xu, Jiasheng Mu, Jing Xiao, et al.
Journal of Cancer|February 27, 2016
The Traditional Chinese Medicine Baicalein Potently Inhibits Gastric Cancer CellsJiasheng Mu, Tianrun Liu, Lin Jiang, et al.
Oncology Letters|April 30, 2017
Thioridazine has potent antitumor effects on lung cancer stem-like cellsJiani Shen, Buyun Ma, Xinmin Zhang, et al.
Molecular Biotechnology|August 14, 2014
GFP stable transfection facilitated the characterization of lung cancer stem cellsNa Li, Yu Yang, Miao Ding, et al.
Journal of Cellular and Molecular Medicine|February 17, 2015
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirusYu Yang, Haineng Xu, Weidan Huang, et al.
Chemical Biology & Drug Design|March 16, 2019
Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switchLiping Chen, Qian Li, Zhiwei Zheng, et al.
Journal of Cellular and Molecular Medicine|June 11, 2014
Altered β1,6-GlcNAc branched N-glycans impair TGF-β-mediated epithelial-to-mesenchymal transition through Smad signalling pathway in human lung cancerNa Li, Haineng Xu, Kun Fan, et al.
BMC Cancer|September 16, 2014
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effectHaineng Xu, Zhengxuan Shen, Jing Xiao, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cancer Treatment and Research|November 17, 2023
Combination DNA Damage Response (DDR) Inhibitors to Overcome Drug Resistance in Ovarian CancerDimitrios Nasioudis, Erin M George, Haineng Xu, et al.
Journal of Cancer|January 22, 2019
High Expression of Indoleamine 2, 3-Dioxygenase in Adenosquamous Lung Carcinoma Correlates with Favorable Patient OutcomeWenjuan Ma, Hao Duan, Rongxin Zhang, et al.
American Journal of Cancer Research|April 14, 2016
CD24 negative lung cancer cells, possessing partial cancer stem cell properties, cannot be considered as cancer stem cellsHaineng Xu, Jiasheng Mu, Jing Xiao, et al.
Journal of Cancer|February 27, 2016
The Traditional Chinese Medicine Baicalein Potently Inhibits Gastric Cancer CellsJiasheng Mu, Tianrun Liu, Lin Jiang, et al.
Oncology Letters|April 30, 2017
Thioridazine has potent antitumor effects on lung cancer stem-like cellsJiani Shen, Buyun Ma, Xinmin Zhang, et al.
Molecular Biotechnology|August 14, 2014
GFP stable transfection facilitated the characterization of lung cancer stem cellsNa Li, Yu Yang, Miao Ding, et al.
Journal of Cellular and Molecular Medicine|February 17, 2015
Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirusYu Yang, Haineng Xu, Weidan Huang, et al.
Chemical Biology & Drug Design|March 16, 2019
Design and optimize N-substituted EF24 as effective and low toxicity NF-κB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switchLiping Chen, Qian Li, Zhiwei Zheng, et al.
Journal of Cellular and Molecular Medicine|June 11, 2014
Altered β1,6-GlcNAc branched N-glycans impair TGF-β-mediated epithelial-to-mesenchymal transition through Smad signalling pathway in human lung cancerNa Li, Haineng Xu, Kun Fan, et al.
BMC Cancer|September 16, 2014
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effectHaineng Xu, Zhengxuan Shen, Jing Xiao, et al.
Pageof 3